跳至主要内容
临床试验/KCT0001093
KCT0001093已完成未知

A Double-blind, Randomized, Parallel, Placebo-active Controlled, Multi-center Phase II Clinical Trial to Investigate the Efficacy and Safety of YH14642 Following 12-week Oral Administration in Patients With Chronic Periodontal Disease

Yuhan0 个研究点目标入组 162 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Yuhan
入组人数
162

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. Healthy male and female aged above 20
  • 2. who has chronic periodontal disease during screening
  • 3. Provision of signed written informed consent

排除标准

  • 1)Subject who is hypersensitive to drug
  • 2)Suject who has history or presence of clinically significant diseas
  • 3)Subject who stopped smoking within 1 months before the treatment or weren't able to stop smoking during the hospitalization
  • 4)Medically unacceptable contraception used during the clinical trial
  • 5)Subject who participated in another clinical trial within 1 months before enrolled in this study
  • 6)Volunteers considered not eligible for the clinical trial by the investigator (study doctor) due to reasons including laboratory test results, ECGs, or vital signs.

研究者

发起方
Yuhan

相似试验